Prevention & Chronic Conditions

Broadcast

Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Management of Hyperkalaemia in Patients with Cardiorenal Disease

Published:

29 April 2026

Citation:

Cardiac Failure Review 2026;12:e10.

Integrated Cardio-oncology Service

Published:

29 April 2026

Citation:

Cardiac Failure Review 2026;12:e09.

Lipoprotein(a): A Risk Factor and Biomarker in Heart Failure

Published:

20 April 2026

Citation:

Cardiac Failure Review 2026;12:e07.

MicroRNAs for Cardiac Regeneration

Published:

22 September 2025

Citation:

European Cardiology Review 2025;20:e26.